Psychiatry and Neurology, Neurology · Brooklyn, NY
NPI
1811997323
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
263 7th Ave
Brooklyn, NY, 11215
Phone (718) 246-8614
Groups this clinician bills Medicare through
Medicare paid, 2024
$176K
15,060 services
Medicare patients, 2024
370
Average age 75
Drug cost, 2024
$4.1M
3,809 prescriptions
Company payments, 2025
$16K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daryl J Victor was code J0585 (injection, onabotulinumtoxina, 1 unit), 13,600 times for 29 patients. In total Daryl J Victor billed 15,060 services in 33 codes, and Medicare paid $176K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 13,600 | 29 | $4.98 | $68K |
| 99214 Office E&M - Established | Office | 241 | 161 | $102.21 | $25K |
| 99213 Office E&M - Established | Office | 199 | 142 | $74.78 | $15K |
| 99215 Office E&M - Established | Office | 166 | 105 | $151.97 | $25K |
| 99232 Hospital E&M - Subsequent | Facility | 53 | 22 | $71.30 | $3,779 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 50 | 40 | $14.57 | $728 |
| 99231 Hospital E&M - Subsequent | Facility | 47 | 23 | $45.02 | $2,116 |
| 64616 Musculoskeletal | Office | 31 | 13 | $168.52 | $5,224 |
| 99205 Office E&M - New | Office | 28 | 28 | $170.62 | $4,777 |
| 99222 Hospital E&M - Initial | Facility | 27 | 26 | $113.72 | $3,071 |
| 99223 Hospital E&M - Initial | Facility | 18 | 17 | $155.19 | $2,793 |
| 99233 Hospital E&M - Subsequent | Facility | 18 | 11 | $107.27 | $1,931 |
| 99221 Hospital E&M - Initial | Facility | 16 | 16 | $75.77 | $1,212 |
| 99204 Office E&M - New | Office | 13 | 13 | $123.08 | $1,600 |
| 99203 Office E&M - New | Office | 12 | 12 | $104.15 | $1,250 |
By year: 2022 $147K for 9,699 services; 2023 $173K for 12,660 services; 2024 $176K for 15,060 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daryl J Victor prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 420 prescriptions and refills. In total Daryl J Victor wrote 3,809 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 420 | 963 | 122 | $19K |
| Quetiapine Fumarate Generic | 195 | 448 | 57 | $4,265 |
| Donepezil Hcl Generic | 135 | 344 | 39 | $7,385 |
| Ropinirole Er Ropinirole Hcl | 116 | 255 | 38 | $17K |
| Nuplazid Pimavanserin Tartrate | 112 | 199 | 23 | $976K |
| Gabapentin Generic | 107 | 272 | 40 | $1,947 |
| Escitalopram Oxalate Generic | 96 | 250 | 34 | $1,226 |
| Rivastigmine Rivastigmine Tartrate | 91 | 203 | 25 | $5,833 |
| Rytary Carbidopa/Levodopa | 88 | 151 | 21 | $103K |
| Nortriptyline Hcl Generic | 82 | 202 | 31 | $940 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 74 | 208 | 28 | $4,950 |
| Clonazepam Generic | 72 | 88 | 30 | $990 |
| Amantadine Amantadine Hcl | 69 | 157 | 22 | $3,938 |
| Propranolol Hcl Generic | 66 | 190 | 30 | $1,368 |
| Levetiracetam Generic | 64 | 160 | 26 | $2,508 |
Brand drugs: - claims; generic drugs: 2,964 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daryl J Victor $16K ($16K in general payments such as food, travel and fees) from 27 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $12K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.